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Comment on the Significance of Positive
Carcinogenicity Studies Using Gavage as
the Route of Exposure
by Frederica Perera,* Troyan Brennan,t and James R. Foutst
There is continuing controversy, extending into regulatory matters, overthe significance to human health
ofpositive results in carcinogenicity studies in animals usingthe gavage technique as the route ofexposure.
Ourreview ofa nonrandomsample of117 chemicals orchemical processes listedasknownorreasonably antici-
pated to be carcinogenic in the National TbxicologyProgram's ThirdAnnual Report on Carcinogens provides
support forthe validity ofthe gavage route in such studies. Twenty-three chemicals amongthe 117 substances
and processes listed were positive by gavage. Twenty ofthese 23 chemicals were also appropriately studied
by at least one other route ofexposure. Thus, we were able to evaluate the extent to which positive gavage
results were confirmed by another route ofexposure in this sample. Nineteen (or 95%) ofthe twenty chemi-
cals were positive forcarcinogenicity by at least one other nongavage route in carcinogenicity bioassays. More-
over, in each ofthese 19 cases, positive carcinogenesis results were obtained bya nongavage route in the same
species ofanimal where gavage administration led to the induction ofcancer. All ofthe 23 gavage-positive
chemicals induced tumors distal to the site ofadministration in at least one study, as did all 15 chemicals
which were alsopositive by subcutaneousinjection. We emphasize, however, the limited scope ofoursurvey.
We have notevaluated all chemicals that have tested positive by gavage and by at least one alternative route,
nor have we assessed those chemicals found to be negative by the gavage route. Despite this limitation, our
review suggests that, although gavage may not be the general method ofchoice forchemical administration,
the results ofstudies wherein this route was employed aremeaningful as a basis for assessingpotential car-
cinogenic hazards.
Introduction
The scientific and regulatory communities generally
agree that chemicals positive in properly conducted car-
cinogenesis studies should be regarded, forpractical pur-
poses, as likely to be carcinogenic in humans (1,2). How-
ever, positive results on a number of commercially
important substances in animal studies wherein gavage
was the route ofadministration have triggered a debate
about the validity ofthose results (3,4). This has been es-
pecially true when vegetable oil was the vehicle. The de-
bate centers around the possibility that results obtained
by the gavage route may be misleading-especially that
gavage may lead to an excess offalse positive results as
compared with other routes (3). This question is particu-
larly relevant to the assays conducted in the National Ibx-
icology Program (NTP) where, in the past, the gavage
route was often used in carcinogenesis studies. This de-
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bate about the reliability ofthe gavage route was central
in discussions aboutthe cancellation ofthepesticide ethy-
lene dibromide (EDB) by the Environmental Protection
Agency(EPA)(5-7). However, like two othergavage-posi-
tive chemicals of regulatory importance, 1,2-dibromo-
3-chloropropane (8) and benzene (9-11), EDB hasrecently
been demonstrated to be carcinogenic by the inhalation
route as well.
Inprinciple and where possible, carcinogenicity bioas-
says should employ a route relevant toanticipated human
exposure (4), but this may not always bepracticable. For
example, in the case ofwaterinsoluble, volatile, or unsta-
ble compounds, or substances that areunpalatable to test
animals, gavage maybe the route ofchoice to ensure ade-
quate and quantifiable dose and absorption of the test
substance. The vehicle chosen may be oil (usually edible
vegetable oil) to overcomeproblems such as hydrophobic-
ity. Forthese practical reasons, gavage becomes the most
convenient and accurate route ofadministration formany
tests (2).
Concern hasbeenvoiced thatthe oil vehicle usedin ad-
ministering some chemicalsbygavage may alterthe rate
ofabsorption, distribution, excretion, and metabolism ofPERERA, BRENNANAND FOUTS
the test substance, ormay affect hormonal status, cell di-
vision orotherfactors thatmodify tumorigenic responses
(12-14). At the present time, there is only limited infor-
mation regarding the ability of the gavage vehicle to
modify the pharmacokinetics oftest substances, and the
significance ofnutritional, physiological, and biochemical
effects induced by various types ofoil gavage is not well
established. However, it should be pointed out that the
vegetable oil used inmost studies is identical to one ofthe
common constituents ofmost human diets. There are also
some reports ofa tumor-promoting effect ofoils used in
administering chemicals by gavage (4,14,15) and of an
overall elevated incidence ofpancreatic acinar adenoma
in male F344/N rats receiving corn oil bygavage in some
studies (16). Yet there havebeenmarked variations in the
incidence of both these effects, and the most consistent
effect in gavage studies using corn oil as the vehicle was
a decrease in the incidence of leukemia (17).
It has also been argued that in most cases (except for
ingested materials including drugs to be taken orally), the
gavage route bears little relationship to anticipated hu-
man exposure to the toxic substance (18). However, many
materials that are inhaled will end up in the stomach,
often in large amounts. This is particularly true ofmate-
rials suspended as particles in the air. Inhaled particles,
deposited in the lung, can be transported up the respira-
tory tree and then swallowed. Thus, oral ingestion is a
common route ofhuman exposure (ultimately) to carcino-
gens in the environment or workplace.
Questions about the biological effects ofgavage and ve-
hicles used in administration are difficult to resolve be-
cause they are likely to be affected by factors such as an-
imal age or weight, species and strain, the amount and
type ofvehicle (oil)used, the presence or absence offood
in the stomach at the time of gavage, the time and fre-
quency of the gavage, and the skill of the person ad-
ministering the gavage (to minimize the stress orinjury
to the animal). Rates ofabsorption ofoilborne materials
fromthe site ofadministrationgreatly depend on all these
factors, as well as the rate ofstomach emptying, which is
also affected by anxiety, light/dark cycles, etc. Adequate
information on suchfactors israrely available forgavage
nor for any other route. (Further research is obviously
needed on all these questions.)
However, carcinogenicity data exist that can be ana-
lyzed to compare the results ofvarious routes ofadmin-
istration atleastqualitatively. We have therefore reviewed
a recent NTP summary oftest data (19) to compare the
results ofgavage with otherroutes ofadministration. We
examined the question: Does the use of gavage as the
route of administration in the carcinogen bioassay fre-
quently give positive data that are not confirmed when
the same chemicals are tested by other routes of ex-
posure?
Methods
Our source ofdataaboutcarcinogenesis studies was the
NTPThird Annual Report onCarcinogens, alistingof117
chemicals or chemical processes known or reasonably an-
ticipated to be carcinogens (19). Of these, 23 chemicals
were positive in experiments using gavage as the route
ofexposure. Each ofthe23 chemicalswasreviewedto see
if, according to the NTP orthe International Agency for
Research on Cancer (IARC) data base, tumors had been
inducedby the same chemical via other routes ofadmin-
istration, andinthe same oradifferentanimal species(Ta-
ble 1). We have relied on the conclusions ofthe NTP and
IARC asto whetherthe chemicalwas carcinogenic in the
individual studies andhave notperformed additional sta-
tistical analysis ofthe significance ofresults characterized
by these agencies as positive.
Table 1 compares the results ofgavage studies to other
routes ofexposure. Several, but not all, conceivable alter-
native routes are compared. Often only one study was
cited for each route, although in many cases there are
reports of more than one positive study by the same
route. Tb avoid possible falsepositive results in studies us-
ingthe SC routeofadministration, positiveresultswhere
the tumors produced were distal to the site of injection
were distinguished from those where the only tumors
seen arose at the injection site (20).
Results and Discussion
Of the 23 chemicals or processes listed in the NTP
Third Annual Report on Carcinogens and administered
bythegavage route(19 ofwhich arelistedinTable 1), only
4 [chloroform (21), dichloroethane (22), polybrominated
biphenyls (23), and selenium sulfide (24)] have not been
reported also as positive in at least one other study
wherein a different route of administration was used.
However, ofthese 4, only selenium sulfide has been ade-
quately studied by an alternative (in this case dermal)
route. Wefound no reports ofstudies ofPBBswhere non-
gavage routes were employed. Althoughnegative results
were obtained when chloroform and dichloroethane were
injected IP in rats, these authors and the IARC consider
this test systemlimited and view thenegative results of
such studies as insufficient evidence ofnoncarcinogenic-
ity (25). Thus, selenium sulfide is the only chemical
studied by at least one appropriate alternative route
whose positive results by the gavage route are not con-
firmed (24,26). In addition, every chemical listed in Table
1 was found to be positive in a study using a nongavage
route in the same species of animal that gave positive
results when the chemical was administered by gavage.
Table 1 shows that, in atleastone study, each chemical
induced tumors distal to the site ofapplication (stomach).
This was also true for the 15 substances in this data set
studied by the SC route. In at least one SC experiment,
all 15 chemicals caused tumors at sites other than (some-
times in addition to) the injection site: 4-amino-biphenyl,
benzidine, benzo[a]pyrene, carbon tetrachloride, cycasin,
dibenz[a,h]anthracene, 7H-dibenzo[c,g]carbazole, diethyl-
stilbestrol, dimethylbenzidine, 2-naphthylamine, N-nitro-
sodibutylamine, N-nitrosodiethylamine, N-nitrosodimeth-
ylamine, N-nitroso-N-methylurea, andurethane. Thus, the
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Table 1. Chemicals positive by gavage and other routes.a
Chemical
Acrylonitrile
4-Aminobiphenyl
Benzidine
Benzo[a]pyrene
Carbon tetrachloride
Cycasin
Dibenz[a,h]anthracene
7H-dibenzo[c,glcarbazole
Diethylstilbestrol
Dimethylbenzidine
Hydrazine
2-Naphthylamine
N-Nitrosodibutylamine
N-nitrosodiethylamine
Species
Rat
Rat
Rat
Mouse
Mouse
Rat
Rat
Rat
Rat
Hamster
Hamster
Mouse
Rat
Rat
Mouse
Mouse
Mouse
Mouse
Hamster
Hamster
Mouse
Mouse
Rat
Rat
Mouse
Mouse
Mouse
Rat
Mouse
Mouse
Mouse
Rat
Mouse
Mouse
Mouse
Mouse
Hamster
Rat
Mouse
Mouse
Rat
Rat
Rat
Mouse
Rat
Mouse
Mouse
Mouse
Mouse
Rat
Hamster
Dog
Hamster
Hamster
Mouse
Mouse
Hamster
Hamster
Hamster
Hamster
Hamster
Route of
administration
Gavage
Inhalation
Drinking water
Gavage
Drinking water
Subcutaneous
Gavage
Subcutaneous
Intraperitoneal
Oral
Gavage
Gavage
Intrabronchial implant
Intratracheal implant
Diet
Subcutaneous
Intraperitoneal
Subcutaneous
Intrabronchial implant
Mouth/spray
Gavage
Oral
Inhalation
Subcutaneous
Gavage
Subcutaneous
Topical
Diet
Gavage
Subcutaneous
Topical
Inhalation
Gavage
Topical
Subcutaneous
Bladder, implant
Intratracheal
instillation
Subcutaneous
Gavage
Diet
Subcutaneous
Gavage
Subcutaneous (pellets)
Gavage
Gavage
Oral
Gavage
Diet
Subcutaneous
Diet
Diet
Diet
Gavage
Subcutaneous
Diet
Subcutaneous
Gavage
Oral
Topical
Inhalation
Subcutaneous
Tumor site(s)
Forestomach, breast
Zymbal gland, breast, forestomach, brain, skin
Brain, Zymbal gland, stomach
Bladder
Bladder, angiosarcoma, heptocellular neoplasms
Large intestine, breast, uterus
Breast
Liver, Zymbal gland, local (injection site)
Mammary, Zymbal gland
Liver
Forestomach, trachea
Mammary
Lung, bronchus
Trachea
Stomach, lung, leukemias
Lung, breast
Lung, lymphoma
Local (injection site)
Bronchus
Skin, trachea, stomach
Liver
Liver
Liver
Liver, thryoid, spleen
Liver, kidney
Liver, lung
Liver, kidney
Liver, kidney, lung, intestine
Breast, forestomach, intestine, lung
Local (injection site), skin, lung
Skin
Lung
Forestomach, liver, lung
Skin
Local (injection site), liver
Bladder
Lung, bronchus, trachea, forestomach
Skin
Breast
Breast
Pituitary
Breast
Skin, Zymbal and preputial glands, breast, liver,
intestine, forestomach
Liver, lung
Liver, lung
Liver, lung
Liver
Liver
Liver, local (injection site)
Bladder
Bladder, liver
Bladder
Bladder, trachea, lung, forestomach
Bladder, trachea, lung
Forestomach, lung, liver
Liver
Lung, trachea
Stomach, esophagus
Nose
Lung, trachea, bronchi
Nose, lung, trachea, liver, stomach
Reference
(27)
(27)
(28)
(29)
(30)
(31)
(32)
(33)
(33)
(34)
(35)
(36)
(37)
(37)
(38)
(39)
(39)
(40,41)
(37)
(35)
(21,42,43)
(44)
(44)
(35,43)
(46)
(46,47)
(48)
(49)
(36,50)
(41)
(51)
(52)
(53
(54,55)
(54)
(54)
(57)
(55)
(58)
(59)
(60)
(32)
(61)
(62)
(62)
(63)
(56)
(56,64)
(64)
(56)
(34)
(64)
(65)
(65)
(66)
(67)
(68)
(69)
(69)
(69)
(69)
(Continued on next page)
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Table 1. (Continued)
Route of
Chemical Species administration Tumor site(s) Reference
Hamster Intraperitoneal Nose, trachea, liver (69)
Rat Inhalation Liver (70)
Rat Oral Liver, esophagus, nose (67,71,72)
Rat Intravenous Liver, mouth, pharynx, esophagus (68)
Mouse Subcutaneous Liver, lung, nose (72)
Mouse Topical Nose (73)
N-Nitrosodimethylamine Hamster Gavage Liver, stomach (75)
Hamster Subcutaneous Liver, lung, nose (76)
Rat Inhalation Nose, pituitary, kidney (72)
Rat Oral Liver, kidney (72)
Rat Diet Liver, kidney, lung (77,78)
Mouse Subcutaneous Lung, breast, local (site of injection) (79)
N-Nitroso-N-methylurea Rat Gavage Kidney, stomach, small intestine, large intestine, (80)
skin, jaw
Rat Oral Kidney, brain (81)
Rat Topical Skin (82)
Hamster Intratracheal All parts of pulmonary tree, esophagus, (83)
instillation forestomach, skin
Hamster Topical Skin (82)
Mouse Subcutaneous Lymphoma, lymphosarcoma (84)
Mouse Topical Skin (82)
2,3,7,8-Tetrachlorodi- Rat Gavage Thyroid, liver (85)
benzo-p-dioxin Mouse Gavage Thyroid, liver (85)
Mouse Topical Skin (integumentary system) (86)
Rat Diet Liver, lung, nose, hard palate, adrenal cortex (85)
Urethane Mouse Gavage Liver, lung, forestomach, leukemia, reticulum cell (87)
Mouse Inhalation Lung (88)
Mouse Oral Lymphoma, lung, skin (89)
Mouse Subcutaneous Lymphoma, lung (37)
Mouse Topical Skin, lung, liver (90)
Vinyl chloride Rat Gavage Zymbal gland, kidney, liver, skin, brain, breast (91)
Rat Interperitoneal Kidney, subcutaneous (91)
Rat Inhalation Zymbal gland, kidney, liver, skin (91,92)
Hamster Inhalation Liver, skin, forestomach, lymphoma (91,92)
possible objection that studies ofcarcinogenesis wherein
the SC route ofadministration was used might be flawed
by the finding oftumors only at the site ofinjection does
not seem to apply to ouranalysis. The SC route was there-
fore used to validate the results of studies using the
gavage route. However, we did not exclude from the ta-
ble carcinogenic responses at the site of administration
(whether this be in the skin after SC injection or in the
forestomach after gavage) since these are also informa-
tive. There can be many reasons for such results, among
them the longer residence time for the chemical sub-
stance at this site. Carcinogenicity is a function of ex-
posure (both dose and time), which varies so widely from
one situation to another depending on animal age, sex,
strain of the animal, site, vehicle, and dose that all posi-
tive results should be carefully considered. Unless it can
be shown that factors that cause tumors at the site ofad-
ministration do not operate distally, it seems reasonable
to consider administration site tumors asbiologically rele-
vant. In fact, intermittent, high concentrations ofcarcino-
genic chemicals at sites ofentry are frequent in humans.
As mentioned earlier, in an analysis ofthe NTP histor-
ical control data base and of nearly 300 carcinogenesis
studies carried out by the National Cancer Institute and
NTP (17), some concern was raised about the use of an
oil vehicle in gavage since in male F344/N control rats
receiving corn oilbygavage there was an increase inpan-
creatic acinarcelladenoma and adecrease inleukemia as
comparedwith untreated controls. Interpretation ofthese
results is difficult. First, effects were variable from one
study to another, and no other tumor incidences seemed
to be affected by the gavage. Second, in no gavage study
using corn oil as the vehicle was the increased incidence
in pancreatic acinar cell tumors the sole evidence of car-
cinogenicity of any test chemical (17).
In summary, the present review seeks to answer a sim-
ple question: Is the gavage route giving a high rate of
false positive results in asample ofchemicals tested? This
was not the case in the survey we conducted. Nor would
we anticipate a different result if additional chemicals
from the subsequent NTP Annual Reports were included
in a similar survey, as they would have been selected ac-
cording to the same criteria as in the Third Annual Re-
port. However, we emphasize that this survey is a first
step in evaluation of the question at hand. We have not
perfonned aglobal evaluation ofallgavage-positive chem-
icals that have been adequately testedby atleast one ad-
ditional route. Nor have we assessed gavage-negative
chemicals. Both were outside the scope ofthis report. In
particular, evaluation ofnegative studies would have re-
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quired a critical review ofthe design and power of each
study to exclude possible false negatives. Despite these
limitations, the data suggest that gavage studies can pro-
vide valuable evidence thatmightbeusedinassessingthe
potential ofa chemical to be ahuman carcinogen andthat
the results of carcinogenesis studies using the gavage
route ofadministration should not be discounted. In this
sample ofchemicals, in every casebutone, positive results
bygavage were confirmedby assaysusingotherappropri-
ate routes of administration.
The authors thank Dr. Ernest E. McConnell and colleagues at NIEHS
forvaluable suggestions, Lisa Levine and Shelley Hearne for excellent
research assistance, and Jan Roby for her fine technical support.
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